AstraZeneca's Tagrisso slashes death risk in certain post-surgery lung cancer patients 05/06/2023 (VOVWORLD) - AstraZeneca’s lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of lung cancer who were diagnosed early enough to...